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Summary
General anesthesia remains a mysterious phenomenon,
even though a number of compelling target proteins and
processes have been proposed [1]. General anesthetics
such as isoflurane abolish behavioral responsiveness in
all animals, and in the mammalian brain, these diverse
compounds probably achieve this in part by targeting
endogenous sleep mechanisms [2, 3]. However, most
animals sleep [4], and they are therefore likely to have
conserved sleep processes. A decade of neurogenetic
studies of arousal in Drosophila melanogaster have identi-
fied a number of different neurons and brain structures
that modulate sleep duration in the fly brain [5–9], but it
has remained unclear until recently whether any neurons
might form part of a dedicated circuit that actively controls
sleep and wake states in the fly brain, as has been proposed
for themammalian brain [10]. We studied general anesthesia
in Drosophila by measuring stimulus-induced locomotion
under isoflurane gas exposure. Using a syntaxin1A gain-
of-function construct, we found that increasing synaptic
activity in different Drosophila neurons could produce
hypersensitivity or resistance to isoflurane. We uncover
a common pathway in the fly brain controlling both sleep
duration and isoflurane sensitivity, centered on monoamin-
ergic modulation of sleep-promoting neurons of the fan-
shaped body.
Results and Discussion
Stimulus-Induced Locomotion Anesthesia Endpoint
Recent Drosophila studies have identified sleep- and wake-
promoting circuits in the fly brain, converging on the dorsal
fan-shaped body of the central complex [9, 11, 12]. Consid-
ering the sleep-promoting role that general anesthetics may
play on the mammalian brain [2, 3], these findings in
Drosophila raise the question of whether general anesthesia
may also be working in flies through endogenous sleep path-
ways. If sleep in Drosophila is indeed an active brain process,
then activation of sleep-promoting neurons in the fly brain
should promote general anesthesia, whereas activation of
wake-promoting neurons should oppose this process.
Sleep and anesthesia, although describing a similar behav-
ioral endpoint, are measured differently in Drosophila. Sleep
is typically quantified by inactivity criteria [13, 14], resulting
in sleep duration measures over several days and nights*Correspondence: b.vanswinderen@uq.edu.au(Figure 1A), whereas general anesthesia requires an acute
measure of behavioral responsiveness to distressing stimuli
under gas exposure. We developed a paradigm to quantify
the effect of volatile anesthetic (VA) gas on startle behavior in
flies (Figure 1B; see also Supplemental Experimental Proce-
dures available online). Without any VA (0% isoflurane), wild-
type flies responded reliably to mechanical vibrations by
increased locomotion (measured by velocity) compared to
baseline (Figures 1B and S1A–S1D). Adding isoflurane (Fig-
ure S1E) abolished stimulus-induced locomotion (Figure S1D),
yielding an EC50 ofw0.2 vol % for the startle response in wild-
type flies (Figure 1B); the same EC50 was observed when
different batches of flies were assayed at each isoflurane
concentration (Figure S1F). The EC50 is the VA concentration
resulting in half-maximal behavior, which is estimated by
logistic regression of the data (see Supplemental Experimental
Procedures). By using this highly sensitive isoflurane endpoint
(see also [15]), we were able to investigate the circuitry modu-
lating general anesthesia phenotypes in the fly brain and then
contrast these to sleep duration effects in transgenic strains.
Increasing Synaptic Release in Different Circuits Produces
Resistance and Hypersensitivity to Isoflurane
To investigate how tissue-specific synaptic activity might
modulate anesthesia phenotypes, we expressed a mutant
form of syntaxin1A (Syx3–69) [16] in different brain neurons
(Figure 2A), using the UAS-Gal4 gene expression system
[17]. Syntaxin1A is a crucial membrane-bound component of
the SNARE complex, required for fusing presynaptic vesicles
to the neuronal plasma membrane [18]. The Syx3–69 mutation
decreases the energy required for vesicle fusion with the
plasma membrane (Figure 2B) [16], resulting in increased
neurotransmitter release, as measured at the larval neuromus-
cular junction (Figures 2B and 2C).
Increasing synaptic release with UAS-Syx3–69 in adult flies
across a variety of different neuronal systems and structures
yielded significantly different results, either increasing or
decreasing isoflurane potency (estimated by the EC50) com-
pared to genetic background controls (Figures 2D and S2).
Interestingly, brain-wide expression of UAS-Syx3–69 with
elav-Gal4 rendered flies hypersensitive to isoflurane. Expres-
sion of UAS-Syx3–69 more narrowly in c380 and D42, which
express in motor neurons [19], also produced hypersensitivity
to isoflurane, whereas expression of UAS-Syx3–69 in
GABAergic neurons (with theGad1-Gal4 driver [20]) and gluta-
matergic neurons (with the vGlut-Gal4 driver [21]) did not
produce any significant hypersensitivity (Figures 2D and S2).
Investigation of UAS-Syx3–69 effects in the central brain re-
vealed two Gal4 drivers expressing in similar layers of the
fan-shaped body (FB) [9] of the central complex (104y-Gal4/
UAS-Syx3–69 and C5-Gal4/UAS-Syx3–69; see Figure 2E) that
produced significant hypersensitivity to isoflurane compared
to controls (Figures 2D and S2), whereas drivers expressing
in other FB neurons (NP6561 and NP2320) or other brain
structures (including the mushroom bodies) had no effect. In
contrast, UAS-Syx3–69 expression in monoamine-expressing
neurons (dopamine and octopamine/tyramine) produced iso-
flurane resistance (Figures 2C and S2). That these effects
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Figure 1. Sleep Duration and General Anesthesia
(A) Left panel: schema of sleep setup. Individual fly locomotion across the
midline (dashed line) is tallied by infrared beam interruptions over several
days; epochswithout any crossings for 5min or longer are counted as sleep.
Middle panel: average sleep (min/hr 6 SEM) for wild-type (CS) females (n =
32). Right panel: summary data for day and night sleep (***p < 0.001, by t test
comparing means).
(B) Left panel: schema of anesthesia apparatus. Flies housed individually in
glass tubes respond to vibration stimuli from small motors attached to the
scaffold (represented by dashed circles) by increased locomotion. The
arousal-testing device is housed in a 1 l chamber that can be equilibrated
to different concentrations of anesthetic gas. Middle panel: flies are filmed
and automatically tracked in order to quantify a locomotion profile per fly
(y axis represents horizontal displacement along each tube; x axis repre-
sents time). Right panel: nonlinear regression of normalized stimulus-
induced velocity 6 SEM, under increasing isoflurane concentrations (vol
% atm). The EC50 is the isoflurane concentration resulting in half-maximal
behavior (dotted lines). Inset: estimated EC50 6 standard error of the esti-
mate (SEE) for stimulus-induced locomotion in wild-type females (n = 20).
See Figure S1 for additional information on the assay.
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595might be restricted to the fly central nervous system was sup-
ported by the lack of any effect in Tdc1-Gal4/UAS-Syx3–69
(Figure S3A), which drives expression of octopamine/tyramine
outside the brain [22]. Increasing synaptic release simulta-
neously fromdopaminergic, octopaminergic, and tyraminergic
neurons in Tdc2-Gal4;Th-Gal4/UAS-Syx3–69 flies did not
produce greater isoflurane resistance than that shown by
either Gal4 driver individually (Figure S3B), suggesting a
convergence of effects rather than additive effects. Similarly,
increasing synaptic release simultaneously from dopami-
nergic and serotonergic neurons in Ddc-Gal4/UAS-Syx3–69
flies produced isoflurane resistance that was not greater
than that shown by either the Th or Trh-Gal4 driver individually
(Figure S3C).
To confirm our resistance phenotypes, we expressed
another transgenic construct, UAS-Vr1, which activates
neurons by acute feeding of capsaicin to flies (Figure 3A, left
panel) [9], in Th and Tdc2 neurons. Consistent with our
preceding results, activating dopaminergic and octopaminer-
gic/tyraminergic neurons by feeding capsaicin to Th-Gal4/
UAS-Vr1 and Tdc2-Gal4/UAS-Vr1 adult flies conferred resis-
tance to isoflurane in both strains, compared to sham-fed
controls (Figures 3A, S3D, and S3E). By comparison, similarlytreated Gad1-Gal4/UAS-Vr1 flies or UAS-Vr1/+ controls
showed no significant effect (Figures 3A, S3F, and S3G).
Dopaminergic Modulation of Sleep-Promoting Neurons
Produces Resistance to Isoflurane
The wake-promoting role of dopamine (DA) in Drosophila is
well established [23]. To further confirm the relevance of dopa-
mine to isoflurane sensitivity, we investigated two mutants
impacting dopamine function. dumb2 and fumin are two
mutants that affect dopaminergic signaling in opposite ways.
dumb2 is a hypomorphic allele of the dDA1 receptor (DopR)
resulting in lower dopamine levels [24], whereas fumin is
a mutant for the dopamine transporter gene (dDAT) leading
to an increase in dopamine at the synapse [25]. These muta-
tions have opposite effects on sleep duration [12]. We found
that the mutants also have opposite effects on isoflurane
sensitivity: fumin is resistant compared to genetic background
controls, whereas dumb2 is hypersensitive (Figures 3B, S3H,
and S3I).
Two recent studies identified specific DA neurons that
innervate the dorsal fan-shaped body (dFB) to modulate sleep
duration in Drosophila [11, 12]. We found in our UAS-Syx3–69
screen (Figure 2D) that two sleep-inducing Gal4 lines that
express in the FB (104y and C5; Figure 2E) are hypersensitive
to isoflurane. Therefore, one simple model potentially explain-
ing our anesthesia results is that activation of the 104y and
C5-Gal4 neurons in the FB decreases behavioral responsive-
ness under anesthesia (consistent with their sleep-promoting
role), whereas DA activity inhibits these neurons (in line with
DA’s wake-promoting role). Consistent with this model, DA
innervates the same FB layers that have been suggested to
modulate arousal in 104y and C5-Gal4 strains (Figure 2E)
[11], DopR is highly expressed in the FB [26], and DopR
has been shown to inhibit neurotransmission in Drosophila
cell cultures [27]. To test whether DA modulation of sleep-
promoting neurons controls behavioral responsiveness under
general anesthesia, we targeted the expression of DopR in
the 104y neurons specifically. RNAi-mediated knockdown of
DopR in these neurons produced flies that are hypersensitive
to isoflurane, resembling the dumb2 mutant (Figures 3B and
S3J). Combining fumin and dumb2, in the DATfmn;DA1dumb2
double mutant, abolished fumin-induced resistance (Figures
3B and S3K), confirming the role of this specific DA receptor
in the anesthesia phenotype. Because the dumb2 mutation
harbors a UAS construct [12], we could express wild-type
DopR in different neurons under Gal4 control. We found that
expression of DopR in the sleep-promoting neurons (104y-
Gal4) was sufficient to rescue fumin-induced resistance in
the double-mutant background (Figures 3B and S3K). In
contrast, DopR expression in the mushroom bodies (using
OK107-Gal4 [12]) did not rescue fumin-induced resistance
(Figures 3B and S3K). These results confirm the sufficiency
of the sleep-promoting system encompassed by 104y for
producing isoflurane resistance via DopR.
Sleep-Promoting Neurons Regulate General Anesthesia
Phenotypes
Our data so far suggest that increased dopaminergic modula-
tion of sleep-promoting (104y-Gal4) neurons via DopR results
in isoflurane resistance, and conversely that decreased DA
modulation of sleep-promoting neurons leads to isoflurane
hypersensitivity. This model therefore proposes that the
sleep-promoting neurons are downstream of modulatory
dopaminergic neurons, and that it is synaptic output from
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Figure 2. Effects of Increasing Synaptic Release
(A) UAS-Syx3–69 construct, indicating the position of
the T254L mutation in the H3 domain of the molecule.
TM, transmembrane domain; A, B, C, N-terminal inter-
action domains.
(B) Schema showing vesicle fusion (syntaxin1A
molecule in red) and sample traces of postsynaptic
potentials measured at the larval neuromuscular junc-
tion (NMJ) in wild-type and elav-Gal4/UAS-Syx3–69
animals.
(C) Estimation of neurotransmitter release (normalized
quantal content 6 SEM) at the larval NMJ for elav-
Gal4/UAS-Syx3–69 and control strains (see Supple-
mental Experimental Procedures for additional data).
**p < 0.01 by ANOVA adjusted for multiple compari-
sons; n = 8 for each strain. WT, wild-type.
(D) DEC50 6 SEE (isoflurane vol % atm) for each Gal4
line indicated when combined with UAS-Syx3–69 and
tested as adults. DEC50 is calculated by subtracting
the control EC50 (Gal4/+) from the experimental EC50
(Gal4/UAS-Syx3–69). Each strain was compared to its
genetic control, represented by the zero line on the
y axis, by simultaneous curve-fitting statistics. See
Figure S2 for all dose-response curves. p values
were adjusted for 18 planned comparisons: *p <
0.05, **p < 0.01, ***p < 0.001, calculated by extra
sum-of-squares F test between estimated EC50 of
experimental and control strains; n > 30 flies per group
(see Figure S2 for exact n and p values).Wild-type (CS)
was compared to CS/UAS-Syx3–69. Pan/motor, pan-
neural and motor-neuron expressing; MB, mushroom
body expressing; FB, fan-shaped body expressing.
(E) UAS-GFP expression (green) driven by Tdc2-Gal4
(top left), Th-Gal4 (bottom left), 104y-Gal4 (top right),
and C5-Gal4 (bottom right). A focus on the FB region
is shown for each Gal4, with dorsal and medial FB
layers indicated (arrowheads), with different levels of
intensity as evident by GFP expression. Magenta is
nc82 staining. Scale bar represents 100 mm for all.
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596sleep-promoting neurons specifically that regulates anes-
thesia phenotypes. To test this, we expressed Syx3–69 simulta-
neously in sleep-promoting (104y-Gal4) and wake-promoting
(Th-Gal4) neurons. These flies (104y-Gal4;Th-Gal4/UAS-
Syx3–69) are hypersensitive to isoflurane (Figures 3B and
S3L), suggesting that synaptic output from 104y-Gal4 neurons
overrides DA effects on isoflurane sensitivity. We also found
significant isoflurane hypersensitivity by using a different
way of increasing neuronal excitability in sleep-promoting
neurons [9], in 104y-Gal4/UAS-NachBAC flies (Figure S3M).
Our synaptic manipulation of 104y neurons now narrows the
anesthesia effect (and sleep effect; Figure S4) to their synaptic
output.
We therefore next investigated what the consequence on
general anesthesia would be if synaptic output from sleep-
promoting neurons were blocked. If increased synaptic
release from 104y neurons produces isoflurane hypersensi-
tivity (Figures 2D and 3B), then would decreased synaptic
release from these neurons produce isoflurane resistance?
To test this, we blocked synaptic output from sleep-promoting
neurons using a constitutive tetanus toxin construct, UAS-tnt,
which inactivates the synaptic release machinery [28]. Thismanipulation proved lethal at the pupal
stage (data not shown), so we expressed
tetanus toxin acutely in adult flies by using
a temperature-sensitive repressor of Gal4,
tubulin-Gal80TS [29] (Figure 3C, left panel).Blocking synaptic release from the 104y neurons in adults
produced isoflurane resistance, compared to controls where
synaptic release was not blocked (Figures 3C and S3N). Signif-
icant resistance was also produced by blocking synaptic
release from C5-Gal4 neurons (Figures 3C and S3O), which
have overlapping expression with 104y-Gal4 in the FB (Fig-
ure 2E), indicating that the FB is likely to be involved in modu-
lating the anesthesia phenotype. Acutely blocking synaptic
release from these sleep-promoting neurons also significantly
decreased daytime sleep duration (Figures S4J and S4K).
Isoflurane Anesthesia and Sleep Are Negatively Correlated
The opposing effects that FB activation and monoaminergic
activation have on anesthetic sensitivity mirror the opposing
effect that these neurons have on sleep duration. To determine
the extent to which sleep and general anesthesia phenotypes
are correlated in the fly brain, we measured sleep duration
for strains that yielded significantly different isoflurane sensi-
tivities. These included various UAS/Gal4 lines and mutants
describing the DA-FB pathway uncovered in this study, as
well as their relevant control strains (Figure S4). As shown in
Figure 4, we found a strong negative correlation (r = 20.81,
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Figure 3. Acute Resistance Effects and Mutants
(A) Left: adult UAS-Vr1/Gal4 flies were fed 100 mM capsaicin in food to
activate specific Gal4 neurons. Flies were tested for isoflurane sensitivity
after >12 hr capsaicin exposure. Right:DEC506 SEE for four strains crossed
to UAS-Vr1 following capsaicin exposure, compared to sham-fed controls
(represented by the zero y axis line). p values were adjusted for four com-
parisons: **p < 0.01, ***p < 0.001, calculated by extra sum-of-squares
F test between estimated EC50 of experimental and control strains; n > 30
flies per group (see Figure S3 for exact n and p values and all dose-response
curves).
(B) DEC50 6 SEE for select mutants, UAS-RNAi knockdown, and Gal4
doubles. Each strain is compared to its genetic control strain (represented
by the zero y axis line). p values were adjusted for three comparisons per
set of three: **p < 0.01, *p < 0.05, calculated by extra sum-of-squares
F test between estimated EC50 of experimental and control strains; n > 30
(see Figure S3 for exact n and p values and all dose-response curves).
(C) Left: exposing adult UAS-tnt;Gal80TS/Gal4 flies to heat (32C) acutely
blocks synaptic release in specified Gal4 neurons. Flies were tested for
isoflurane sensitivity at room temperature (25C) after >12 hr heat. Right:
targeting synaptic release in sleep-promoting neurons (104y- and C5-
Gal4) in adults produces isoflurane resistance compared to unheated
controls (represented by the zero y axis line). p values were adjusted for
three comparisons: **p < 0.01, ***p < 0.001, calculated by extra sum-of-
squares F test between estimated EC50 of experimental and control strains;
n = 30 for all experiments (see Figure S3 for exact n and p values and all
dose-response curves).
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Figure 4. Contrasting Sleep Duration and Isoflurane EC50 Data
Scatterplot of DEC50 6 SEE (isoflurane vol % atm) against change in total
daytime sleep duration (Dmin/hr 6 SEM) for data from Figures 2 and 3.
A linear fit is drawn through the data; r = 20.81 (p < 0.0001). Blue star:
sleep-deprived flies; red star: methamphetamine-fed flies. Blue dots:
104y/UAS-Syx3–69, C5/UAS-Syx3–69, dumb2, 104y/UAS-NaChBac; green
dots: CS, Tdc1/UAS-Syx3–69, CS/UAS-tnt;Gal80TS (32C); red dots: Th/
UAS-Syx3–69, Tdc2/UAS-Syx3–69, Trh/UAS-Syx3–69, Ddc/UAS-Syx3–69,
Tdc2+Th/UAS-Syx3–69, 104y/UAS-tnt;Gal80TS (32C), C5/UAS-tnt;Gal80TS
(32C), fumin. All isoflurane dose-response curves are in Figures S2 and
S3; all corresponding sleep profiles are in Figure S4.
Sleep/Wake and General Anesthesia in Drosophila
597p = 0.0001) between daytime sleep duration and isoflurane
sensitivity: resistant flies slept less, and hypersensitive flies
slept more. This tight relationship between daytime sleep
and anesthesia phenotypes was also evident for night-time
sleep (r = 20.64, p = 0.001), and the correlation extended
beyond mutant strains to behavioral and pharmacological
manipulations: sleep-deprived flies slept more and werehypersensitive to isoflurane, whereas methamphetamine-fed
flies slept less and were resistant to isoflurane (Figure 4, blue
and red stars, respectively; Figures S3 and S4).
The negative correlation between isoflurane EC50 and sleep
duration that we have uncovered in Drosophila provides
support for a potential overlap between endogenous sleep
mechanisms and general anesthesia in the fly brain. This
conclusion is consistent with an earlier study showing that
a short-sleeping mutant inDrosophila, shaker, is also resistant
to the general anesthetics isoflurane and sevoflurane [30]. It is
therefore possible that the shaker potassium channel is
involved in regulating neuronal activity levels in the DA-FB
circuit to control both sleep and anesthesia phenotypes. In
mammals, general anesthetics appear to achieve a sedative
effect by activating sleep-promoting neurons in the hypothal-
amus [3]. Whether simpler animals also become anesthetized
by activation of sleep-promoting neurons seems to first
depend on whether those animals really sleep. Our study
confirms the importance of the DA-FB pathway in the fly brain
for Drosophila arousal in general, and our results predict that
the sleep-promoting neurons (e.g., 104y cells) should be acti-
vated under general anesthesia as well as natural sleep.
Supplemental Information
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.cub.2013.02.021.
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